By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovImmune SA 

64 avenue de la Roseraie

Geneva    1211  Switzerland
Phone: 41-22-839-71-41 Fax: 41-22-839-71-42


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
NovImmune SA Appoints Andrew J. Oakley As CFO 3/12/2014 6:59:10 AM
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014 7:02:37 AM
NovImmune SA Initiates Phase I Clinical Study With First-in-Class Anti-TLR4 Monoclonal Antibody 11/28/2012 9:32:14 AM
NovImmune SA Release: European Commission Awards a EUR 6 Million FP7 Grant to Support Clinical Development of NI-0501 to FIGHT HLH 10/15/2012 10:12:51 AM
NovImmune SA Strengthens Board and Management Team 7/10/2012 10:17:31 AM
Genentech (RHHBY) Initiates First-in-Human Study with NovImmune SA's Anti-IL17 Antibody 12/13/2011 9:14:16 AM
NovImmune SA Initiates a Proof-of-Concept Study in Primary Biliary Cirrhosis (PBC) 9/22/2011 10:00:34 AM
ALGENICS and NovImmune SA Announce a Research Collaboration to Express Fully Human Antibodies Using the Microalgal PTA Cell Line 6/22/2011 10:40:13 AM
NovImmune SA Nominates Klaus Strein as New Member of the Board of Directors 5/25/2011 11:24:01 AM
NovImmune SA Raises Additional CHF 20 Million ($19 Million) 12/17/2010 6:14:20 AM
12
//-->